Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Locations
Orders Processing,
Shipping & Receiving,
Warehouse
2 Shaker Rd Suites
B001/B101
Shirley, MA 01464
Production Lab
Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036
Telephone Numbers
Tel: +1 (800) 227-6666
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G138711-10 | 10 µg | $248 |
| LS-G138711-50 | 50 µg | $317 |
Human ACVR2 / ACVR2A Protein (Recombinant Fc/6His,C-terminus) (Ala20-Pro134) - LS-G138711
Human ACVR2 / ACVR2A Protein (Recombinant Fc/6His,C-terminus) (Ala20-Pro134) - LS-G138711
Description:
ACVR2 / ACVR2A Protein LS-G138711 is a Recombinant Human ACVR2 / ACVR2A produced in Mammalian Cells Ala20-Pro134 with Fc/6His,C-terminus tag(s). It is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method). For Research Use Only
Toll Free North America
(800) 227-6666
(800) 227-6666For Research Use Only
Overview
Description:
ACVR2 / ACVR2A Protein LS-G138711 is a Recombinant Human ACVR2 / ACVR2A produced in Mammalian Cells Ala20-Pro134 with Fc/6His,C-terminus tag(s). It is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method). For Research Use Only
Specifications
Type
Recombinant Protein
Target
ACVR2 / ACVR2A
Synonyms
ACVR2A | ACTRIIA | Activin receptor type IIA | ACTRII | Activin A receptor type II | Activin receptor type-2A | ACTR-IIA | Activin A receptor, type II | Activin A receptor, type IIA | ACVR2
Species
Human
Modifications
Unmodified
Conjugations
Unconjugated
Tag
Fc/6His,C-terminus
Region
Ala20-Pro134
Predicted Molecular Weight
41.2 kDa
Expression System
Mammalian Cells
Source Species
Mammal
Purification
Greater than 95% by SDS-PAGE
Usage Summary
Recombinant Human Activin Receptor Type-2A is produced by our Mammalian expression system and the target gene encoding Ala20-Pro134 is expressed with a Fc, 6His tag at the C-terminus.
Bio-Activity
Not Tested
Endotoxin
Less than 1.0 EU/µg protein (determined by LAL method).
Presentation
Lyophilized from a sterile solution in 20 mM PB, pH 7.4, 150 mM NaCl
Storage
Store lyophilized at -20°C to -80°C for up to 1 year. Aliquot and store reconstituted at 4°C to 8°C for up to 1 week, or at -20°C for up to 3 months. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
About ACVR2 / ACVR2A
Publications (0)
Customer Reviews (0)
Popular ACVR2 / ACVR2A Proteins
Source:
Human
Tag:
6His, C-terminus
Source:
Human
Tag:
6His, C-terminus
Source:
Human
Tag:
Myc-DDK (Flag)
Source:
Human
Tag:
Myc-DDK (Flag)
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/3/2024
Date Requested: 11/3/2024
